Brief: Hungary's Richter says Tuyory received positive opinion from EMA committee
27/02/2026 11:27
Feb 27 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU says: IT RECEIVED POSITIVE OPINION FROM EUROPEAN MEDICINES AGENCY'S COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE RECOMMENDING MARKETING AUTHORIZATION IN EUROPE FOR TUYORY TUYORY IS PROPOSED BIOSIMILAR TO ROCATEMRA'S TOCILIZUMAB Source text: [https://bse.hu/newkibdata/129406613/Tocilizumab%20EMA_Feb2026_EN.pdf] Further company coverage: GDRB.BU (Reporting by Anita Komuves) ((KOMUVES.Anita@thomsonreuters.com;))
Recent news on Gedeon Richter
See all newsBrief: Hungary's Richter says US FDA accepted for review its new drug application for Fylrevy
Brief: Hungary's Richter Upgrades 2026 Pharma Clean EBIT Guidance To Double-Digit Growth
development partnership in Tirzepatide
AI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection